One of the most studied lifespan-extending drugs in animals has just failed its test on humans in a 13-week clinical trial co ...
In 2026, Trimology has quickly become one of the most searched weight loss supplements for women over 35, yet with ...
The primary difference between the Wegovy pill and the injection is how you take them and how often. The Wegovy pill is a daily tablet you swallow, while the Wegovy injection is a once-weekly shot you ...
Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...
Novo Nordisk has launched its Wegovy GLP-1 drug in pill form. Amazon is getting into the fight, offering ease and low costs to customers who buy the Wegovy pill on its platform. Up until 2026, GLP-1 ...
Novo Nordisk said it will take legal action again telehealth provider Hims & Hers after Hims announced a cheaper copycat version of Novo's Wegovy weight loss pill. Hims said it would sell a copy of ...
There’s a new semaglutide pill entering the weight-loss market, and it’s aiming to undercut the competition. Hims & Hers, the online pharmaceutical retailer, announced plans to launch a compounded, ...
Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January. Subscribe to read this story ad-free Get unlimited access to ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...
The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...